ANDA 212876, held by Somerset Theraps LLC. Valganciclovir Hydrochloride.
As of Nov 16, 2026, ANDA 212876 (Valganciclovir Hydrochloride), held by Somerset Theraps LLC, was first approved by FDA on Jun 11, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 11, 2024 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Valganciclovir HydrochlorideEQ 450MG BASE ยท tablet;oral | Valganciclovir Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters